did not observe an association between the expression level of SLC29A1 and the prognosis of patients with pancreatic cancer treated with neoadjuvant gemcitabine chemotherapy, potentially due to the limitation that the SLC29A1 evaluation occurred after neoadjuvant chemoradiation.111. The gene discussed is SLC29A1; the disease is familial pancreatic carcinoma.